K. Matzek

Clinical Pharmacokinetics of Clonidine

D. Lowenthal, K. Matzek, T. Macgregor, 1988, Clinical pharmacokinetics.

A Review on Telmisartan: A Novel, Long-Acting Angiotensin II-Receptor Antagonist

K. Matzek, T. Ebner, M. Entzeroth, 2006 .

Pharmacokinetics of transdermally delivered clonidine

K. Matzek, T. Macgregor, J. Keirns, 1985, Clinical pharmacology and therapeutics.

Transdermal Clonidine as an Adjunct to Enalapril: An Evaluation of Efficacy and Patient Compliance

K. Matzek, A. Lewin, D. Weidler, 1992, Journal of clinical pharmacology.

Dose Response and Safety of Telmisartan in Patients with Mild to Moderate Hypertension

K. Matzek, J. Kempthorne-Rawson, David H. G. Smith, 2000, Journal of clinical pharmacology.

Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis

K. Matzek, T. Macgregor, J. Keirns, 2004, European Journal of Clinical Pharmacology.

Oral pharmacokinetics of pirenzepine in man following single and multiple doses

K. Matzek, T. Macgregor, J. Keirns, 1986 .

Effect of food and antacids on the oral absorption of pirenzepine in man

K. Matzek, T. Macgregor, J. Keirns, 1986 .